Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JUNO | AMGN | GILD | CELG | BIIB |
| Company | Juno Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 86.97 | 265.64 | 66.36 | 108.01 | 191.00 |
| High | 87.01 | 265.92 | 66.36 | 108.59 | 191.00 |
| Low | 86.90 | 262.58 | 66.36 | 107.27 | 191.00 |
| Last | 86.96 | 262.75 | 66.36 | 108.24 | 191.00 |
| Change | +0.09 | -1.32 | +0.20 | +0.11 | +0.48 |
| % Change | +0.10% | -0.50% | +0.30% | +0.10% | +0.25% |
| Volume | 3,696,100 | 2,082,700 | 896 | 191,230,496 | 439 |
| 20-Day Average Volume | 4,145,455 | 2,201,900 | 5,923,115 | 16,188,930 | 1,061,037 |
| Previous Close | 86.87 | 264.07 | 66.16 | 108.13 | 190.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 86.09 | 272.96 | 69.88 | 108.17 | 204.87 |
| 20-Day Raw Stochastic | 97.77% | 0.65% | 5.77% | 63.25% | 4.66% |
| 20-Day Relative Strength | 73.72% | 36.64% | 29.08% | 64.69% | 27.67% |
| Weighted Alpha | +175.90 | +4.25 | -24.95 | +46.30 | -38.52 |
| Today's Opinion | N/A | 56% Sell | 100% Sell | 100% Buy | 100% Sell |
| Previous Opinion | N/A | 56% Sell | 100% Sell | 100% Buy | 100% Sell |
| Last Month's Opinion | N/A | 8% Sell | 72% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.42% since 02/26/18 | -2.69% since 04/11/24 | -2.51% since 04/12/24 | -1.97% since 11/13/19 | -3.62% since 04/12/24 |
| Low | 86.60 on 02/27/18 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 189.52 on 04/18/24 |
| High | 87.01 on 03/05/18 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 199.53 on 04/15/24 |
| 1-Month | |||||
| %Chg | +1.57% since 02/05/18 | -3.01% since 03/18/24 | -9.60% since 03/19/24 | +5.14% since 10/18/19 | -12.64% since 03/19/24 |
| Low | 84.77 on 02/20/18 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 189.52 on 04/18/24 |
| High | 87.01 on 03/05/18 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +63.46% since 12/05/17 | -13.71% since 01/18/24 | -23.98% since 01/19/24 | +13.63% since 08/20/19 | -23.59% since 01/19/24 |
| Low | 42.29 on 12/19/17 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 189.52 on 04/18/24 |
| High | 87.01 on 03/05/18 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | +103.75% since 09/05/17 | -7.35% since 10/18/23 | -15.40% since 10/19/23 | +14.14% since 05/20/19 | -25.77% since 10/19/23 |
| Low | 40.11 on 09/06/17 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 189.52 on 04/18/24 |
| High | 87.01 on 03/05/18 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,096,926 | 140,812,720 | 82,374,304 | 77,035,920 | 27,694,178 |
| Shares Outstanding, K | 116,110 | 535,919 | 1,245,077 | 711,714 | 145,361 |
| Annual Sales | 79,360,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -245,580,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 44,820,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -118,130,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 249,700,000 |
| 60-Month Beta | 3.24 | 0.58 | 0.19 | 1.41 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 11/01/17 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 2.95 on 02/13/24 |
| Latest Earnings Date | 03/07/18 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 13.05 |